BCAN's Patient Handbook - Bladder Cancer Basics for the Newly Diagnosed



Donate Now to Support the Bladder Cancer Advocacy Network



Join The Online Bladder Cancer Support Community



The Bladder Cancer Advocacy Network (BCAN) is proud to announce that we have been designated a Marine Corps Marathon (MCM) Charity Partner! BCAN has been allocated 25 guaranteed entries for the 38th Annual Marine Corps Marathon to be held on October 27, 2013; an event that sold out in 2 hours and 41 minutes in 2012.
  • We are looking at building “Team BCAN” to not only run in the event and raise awareness for bladder cancer but to raise needed funds for fostering research and patient education. According to the Marine Corps Marathon, there is not a required qualifying time to participate in the event, but all runners should maintain at least a 14 minute mile pace. In order to become a member of “Team BCAN” and officially have a slot in this year’s race, you must be registered through BCAN.
  • No federal or Marine Corps endorsement is implied.
  • If you are interested in becoming a member of BCAN’s team or have any questions, please contact Larry Rzepka, BCAN’s Executive Director, at lrzepka@bcan.org.
  • Au

    Dr. Jessie Au
    Professor
    Ohio State University

    Dr. Au is a Distinguished University Professor at Ohio State University. Dr. Au received her Pharm.D. and Ph.D. degrees from University of California San Francisco and postdoctoral training at Roswell Park Cancer Institute. Dr. Au is recognized for her accomplishments in pharmaceutical and cancer research.  Her breadth of interests and training in both clinical and basic sciences have allowed Dr. Au to excel in translating her laboratory discoveries in cellular and molecular pharmacology of anticancer drugs into clinical applications.  Dr. Au is among the top 5% recipients of NIH funding over 25 years.

    Dr. Au is a Fellow of American Association for the Advancement of Science and a Fellow of American Association of Pharmaceutical Scientists. Dr. Au is recipient of Distinguished Scholar Award and Davis Chair in Cancer Research from OSU, Research Career Development Award and Merit Award from the National Cancer Institute, and a Research Award from American Association of Pharmaceutical scientists. Dr. Au’s pioneering work in systems translational research has led to her nomination and selection as a semi-finalist for the inaugural NIH Director’s Pioneer Award.

    Dr. Au was Director of Translational Research and Deputy Director of the OSU Comprehensive Cancer Center. Dr. Au has served on numerous NIH Committees and scientific advisory boards of academic centers and pharmaceutical companies, several editorial Boards, and FDA Pharmaceutical Sciences Advisory Committee. For CV click here.